A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
Clinical trial NCT06713564 · COMPLETED
Trial details
- NCT number
- NCT06713564
- Sponsor
- Integro Theranostics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2026-05-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.